aTYR PHARMA ATYR
NASDAQ ATYR
$0.50 0.00 (-0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) EPS (Basic) (2014 - 2026)

aTYR PHARMA's (ATYR) quarterly EPS (Basic) came in at -$0.14 in Q1 2026, up 33.14% YoY from -$0.1 in Q1 2025, and up 13.76% on a QoQ basis from -$0.16 in Q4 2025.

aTYR PHARMA (ATYR) EPS (Basic) (2014 - 2026) Analysis & Trends

aTYR PHARMA (ATYR) has 13 years of EPS (Basic) data on file, last reported at -$0.14 in Q1 2026.

  • Quarterly EPS (Basic) rose 33.14% year-over-year to -$0.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.81 (up 9.04% YoY) and the FY2025 annual result came in at -$2.36, up 8.62% from the prior year.
  • EPS (Basic) advanced to -$0.14 in Q1 2026, from -$0.16 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.14 in Q1 2026 to a low of -$0.71 in Q3 2022.
  • A 5-year average of -$0.33 and a median of -$0.3 in 2023 frame the typical range for EPS (Basic).
  • The widest YoY moves for EPS (Basic): up 94.22% in 2022, down 64.23% in 2022.
  • Tracing ATYR's EPS (Basic) over 5 years: stood at -$0.28 in 2022, then slipped by 5.96% to -$0.3 in 2023, then advanced by 28.48% to -$0.21 in 2024, then grew by 25.35% to -$0.16 in 2025, then increased by 13.76% to -$0.14 in 2026.
  • The last three EPS (Basic) figures came in at -$0.14 (Q1 2026), -$0.16 (Q4 2025), and -$0.3 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 12.62
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 7.59
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.23
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -0.72
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.18
10 aTYR PHARMA 49.54 Mn -7.87 Mn - -0.11

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.13
Mar 31, 2026 -0.14
Dec 31, 2025 -0.16
Sep 30, 2025 -0.30
Jun 30, 2025 -0.25
Mar 31, 2025 -0.21
Dec 31, 2024 -0.21
Sep 30, 2024 -0.26
Jun 30, 2024 -0.32
Mar 31, 2024 -0.35
Dec 31, 2023 -0.30
Sep 30, 2023 -0.33
Jun 30, 2023 -0.36
Mar 31, 2023 -0.46
Dec 31, 2022 -0.28
Sep 30, 2022 -0.71
Jun 30, 2022 -0.48
Mar 31, 2022 -0.49
Dec 31, 2021 -4.87
Sep 30, 2021 -0.43